ID   GSKIP_RAT               Reviewed;         139 AA.
AC   Q5PPI3;
DT   20-JAN-2009, integrated into UniProtKB/Swiss-Prot.
DT   04-JAN-2005, sequence version 1.
DT   29-MAY-2024, entry version 94.
DE   RecName: Full=GSK3B-interacting protein {ECO:0000250|UniProtKB:Q9P0R6};
DE            Short=GSKIP {ECO:0000250|UniProtKB:Q9P0R6};
GN   Name=Gskip {ECO:0000312|RGD:1308470};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   INTERACTION WITH PRKAR2A.
RX   PubMed=20007971; DOI=10.1074/jbc.m109.047944;
RA   Hundsrucker C., Skroblin P., Christian F., Zenn H.M., Popara V., Joshi M.,
RA   Eichhorst J., Wiesner B., Herberg F.W., Reif B., Rosenthal W.,
RA   Klussmann E.;
RT   "Glycogen synthase kinase 3beta interaction protein functions as an A-
RT   kinase anchoring protein.";
RL   J. Biol. Chem. 285:5507-5521(2010).
CC   -!- FUNCTION: A-kinase anchoring protein for GSK3B and PKA that regulates
CC       or facilitates their kinase activity towards their targets. The ternary
CC       complex enhances Wnt-induced signaling by facilitating the GSK3B- and
CC       PKA-induced phosphorylation of beta-catenin leading to beta-catenin
CC       degradation and stabilization respectively. Upon cAMP activation, the
CC       ternary complex contributes to neuroprotection against oxidative
CC       stress-induced apoptosis by facilitating the PKA-induced
CC       phosphorylation of DML1 and PKA-induced inactivation of GSK3B. During
CC       neurite outgrowth promotes neuron proliferation; while increases beta-
CC       catenin-induced transcriptional activity through GSK3B kinase activity
CC       inhibition, reduces N-cadherin level to promote cell cycle progression
CC       (By similarity). May play a role in cleft palate formation and is
CC       required for postnatal life through modulation of the activity of GSK3B
CC       during development (By similarity). {ECO:0000250|UniProtKB:Q8BGR8,
CC       ECO:0000250|UniProtKB:Q9P0R6}.
CC   -!- SUBUNIT: Forms a complex composed of PRKAR2A or PRKAR2B, GSK3B and
CC       GSKIP through GSKIP interaction; facilitates PKA-induced
CC       phosphorylation of GSK3B leading to GSK3B inactivation; recruits DNM1L
CC       through GSK3B for PKA-mediated phosphorylation of DNM1L; promotes beta-
CC       catenin degradation through GSK3B-induced phosphorylation of beta-
CC       catenin; stabilizes beta-catenin and enhances Wnt-induced signaling
CC       through PKA-induced phosphorylation of beta-catenin (PubMed:20007971).
CC       Interacts with GSK3B; induces GSK3B-mediated phosphorylation of GSKIP
CC       and inhibits GSK3B kinase activity (By similarity).
CC       {ECO:0000250|UniProtKB:Q9P0R6, ECO:0000269|PubMed:20007971}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9P0R6}. Nucleus
CC       {ECO:0000250|UniProtKB:Q9P0R6}.
CC   -!- PTM: Phosphorylated by GSK3B. {ECO:0000250|UniProtKB:Q9P0R6}.
CC   -!- SIMILARITY: Belongs to the GSKIP family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC087681; AAH87681.1; -; mRNA.
DR   RefSeq; NP_001014220.2; NM_001014198.2.
DR   RefSeq; XP_006240589.1; XM_006240527.3.
DR   AlphaFoldDB; Q5PPI3; -.
DR   SMR; Q5PPI3; -.
DR   STRING; 10116.ENSRNOP00000006307; -.
DR   PaxDb; 10116-ENSRNOP00000006307; -.
DR   GeneID; 362778; -.
DR   KEGG; rno:362778; -.
DR   UCSC; RGD:1308470; rat.
DR   AGR; RGD:1308470; -.
DR   CTD; 51527; -.
DR   RGD; 1308470; Gskip.
DR   eggNOG; KOG3965; Eukaryota.
DR   HOGENOM; CLU_143747_0_0_1; -.
DR   InParanoid; Q5PPI3; -.
DR   OrthoDB; 3126739at2759; -.
DR   PhylomeDB; Q5PPI3; -.
DR   PRO; PR:Q5PPI3; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0019207; F:kinase regulator activity; IBA:GO_Central.
DR   GO; GO:0051018; F:protein kinase A binding; ISO:RGD.
DR   GO; GO:0034237; F:protein kinase A regulatory subunit binding; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0004860; F:protein kinase inhibitor activity; ISS:UniProtKB.
DR   GO; GO:0008631; P:intrinsic apoptotic signaling pathway in response to oxidative stress; ISS:UniProtKB.
DR   GO; GO:0006469; P:negative regulation of protein kinase activity; ISS:UniProtKB.
DR   GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; ISS:UniProtKB.
DR   GO; GO:0030111; P:regulation of Wnt signaling pathway; ISS:UniProtKB.
DR   Gene3D; 3.30.2280.10; Hypothetical protein (hspc210); 1.
DR   InterPro; IPR037395; GSKIP.
DR   InterPro; IPR007967; GSKIP_dom.
DR   InterPro; IPR023231; GSKIP_dom_sf.
DR   PANTHER; PTHR12490:SF4; GSK3B-INTERACTING PROTEIN; 1.
DR   PANTHER; PTHR12490; UNCHARACTERIZED; 1.
DR   Pfam; PF05303; GSKIP_dom; 1.
DR   SUPFAM; SSF103107; Hypothetical protein c14orf129, hspc210; 1.
PE   1: Evidence at protein level;
KW   Cytoplasm; Nucleus; Reference proteome.
FT   CHAIN           1..139
FT                   /note="GSK3B-interacting protein"
FT                   /id="PRO_0000359876"
FT   REGION          41..45
FT                   /note="Required for PRKAR2A interaction; contributes to a
FT                   protective effect against H(2)O(2)-induced apoptosis"
FT                   /evidence="ECO:0000250|UniProtKB:Q9P0R6"
FT   REGION          115..139
FT                   /note="Interaction with GSK3B and acts as a GSK3B
FT                   inhibitor"
FT                   /evidence="ECO:0000250|UniProtKB:Q9P0R6"
FT   SITE            130
FT                   /note="Required for GSK3B interaction; contributes to a
FT                   protective effect against H(2)O(2)-induced apoptosis"
FT                   /evidence="ECO:0000250|UniProtKB:Q9P0R6"
SQ   SEQUENCE   139 AA;  15557 MW;  3E09486313D001B0 CRC64;
     METDCNPVDL SSMSGFEEGS ELNGFEGTDM KDMQLEAEAV VNDVLFAVNN MFVSKSLPCA
     DDVAYINVET KERNRYCLEL TEAGLRVVGY AFDQVEDHLQ TPYHETVYSL LDTLSPAYRE
     AFGNALLQRL EALKRDGQS
//
